| Application no. and date | 14004427.2 (espacenet) (Federated) (European Patent Register), 20111014 | | Patent/reg. no. and date | DK/EP 2902035, 20180620 | | Publication date | 20150805 | | Priority no. and date | WO PCT/EP2010/006284, 20101014, WO PCT/EP2011/000307, 20110125 | | EP pub. no. and date |
EP 2902035 20150805 | | Effective date | | | Applicant/owner | Xigen Inflammation Ltd., Arch. Makariou III
195 Neocleous House
3030 Limassol, CY | | Applicant ref. no. | 161785 | | Inventor | Combette, Jean-Marc, 515, route de Terret
74140 Saint Cergues, FR,
Deloche, Catherine, 22, Avenue William-Favre
1207 Genf, CH,
Abadie, Claire, 8 rue des francs-tireurs
74000 Annecy, FR | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/03 (2006.01) , A61K 38/04 (2006.01) , A61P 27/02 (2006.01) | | Title | Celle-permeabelt peptid, der er virksomt som inhibitor af JNK-signaltransduktionsvejen, til anvendelse i behandling af inflammatoriske øjensygdomme | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
